CHP Staining: Unlocking a New Therapeutic Strategy for Fibrosis
Fibrosis, the pathological accumulation of collagen and other ECM components, is a major health concern implicated in an estimated ⅓ of all natural deaths. While current anti-fibrotic drugs aim to slow progression, advanced fibrosis is often left untreated, leaving transplantation the only remaining option in many cases. A new therapeutic approach is focusing on...
View Details
Collagen Hybridizing Peptides Validate a Novel Bone Organoid Model
Validate collagen integrity in your biomaterials with 3helix CHPs. Discover how Collagen Hybridizing Peptides (CHPs, 3Helix Inc.) ensure reliable data in tissue engineering and bone remodeling research.
View Details
Revolutionizing Cardiovascular Disease Diagnosis: How Collagen Hybridizing Peptides Unveil Hidden Arterial Damage
Discover how Collagen Hybridizing Peptides (CHPs) transform the diagnosis and treatment of cardiovascular diseases by accurately identifying and targeting damaged arterial collagen. Learn about this innovative technology and its impact on improving patient outcomes.
View Details



